DYNVEO is a French company, founded in 2010, that specializes in developing uncompromisingly pure, high-quality, natural antioxidant and anti-aging products. The company’s approach involves meticulous selection and stringent safety assessments of active ingredients, manufactured under pharmaceutical-grade standards (BPF). This ensures the production of safe, effective supplements that stand apart in the competitive wellness market.
With its slogan, "Aucun compromis. Pureté garantie.", DYNVEO emphasizes commitment to quality and affordability, setting it apart from peers in the industry. The most recent round of seed funding, totaling €5.00M, was secured on June 1, 2022, with contributions from prominent investors BNP Paribas Developpement and Sofilaro. This financial boost is anticipated to fuel further innovation and expansion efforts.
Given its robust commitment to pure and accessible products, DYNVEO presents a compelling opportunity in the natural health product sector, particularly for investors seeking to delve into a growing market with significant potential.